Caricamento...
Trametinib in the treatment of melanoma
INTRODUCTION: Aberrant Mitogen Activated Protein Kinase (MAPK) pathway signaling is a hallmark of melanoma. Mitogen/Extracellular signal-regulated Kinase (MEK) 1/2 are integral components of MAPK signaling. Several MEK inhibitors have demonstrated activity as single agents and in combination with ot...
Salvato in:
| Pubblicato in: | Expert Opin Biol Ther |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684215/ https://ncbi.nlm.nih.gov/pubmed/25812921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1026323 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|